Pharmaceutical emulsions for retroviral protease inhibitors

Details Pharmaceutical emulsions for retroviral protease inhibitors Pharmaceutical emulsions for retroviral protease inhibitors

2005-10-18

2005-10-18

Hui, San-Ming (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C424S450000

Reexamination Certificate

active

06956048

ABSTRACT:
The present invention provides an emulsion formulation with high oral bioavailability containing lecithin as an emulsifier and solubilizing agent to achieve a high loading of the pyranone compound of formula I

REFERENCES:
patent: 5616342 (1997-04-01), Lyons
patent: 5665700 (1997-09-01), Cho et al.
patent: 5693337 (1997-12-01), Suzuki et al.
patent: 5852195 (1998-12-01), Romines et al.
patent: 5952383 (1999-09-01), Metziger et al.
patent: 2 257 359 (1993-01-01), None
patent: WO91/14429 (1991-10-01), None
patent: WO96/39142 (1996-12-01), None
patent: WO98/22106 (1998-05-01), None
patent: WO98/37869 (1998-09-01), None
patent: WO 99 06043 (1999-02-01), None
patent: WO99/06043 (1999-02-01), None
patent: WO 99 06044 (1999-02-01), None
patent: WO99/06044 (1999-02-01), None
Remington's Pharmaceutical Sciences, 18th ed., p. 1172, 1286, 1316 and 1317.

Affiliated with

Also associated with

Rating

Pharmaceutical emulsions for retroviral protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical emulsions for retroviral protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical emulsions for retroviral protease inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3485622